LEO Pharma will manage the distribution ... focuses on a speciality hospital product that complements our existing heparin-based anti-coagulation treatments for cancer-associated thrombosis ...
LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and marketing partnership. The collaboration is aimed at increasing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback